Congress, Ashley Yocum, PhD, highlights how the Beat AML Master Trial advances safe, personalized treatment and expands targeted therapy options for patients with acute myeloid leukemia (AML).

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid ...

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid ...

Aberrant DNA methylation patterns are a characteristic feature of cancer including myeloid malignancies such as acute myeloid leukemia (AML). The mechanisms behind aberrant DNA methylation have ...

An international clinical trial co-led by Roswell Park Comprehensive Cancer Center has demonstrated that the investigational ...

She has acute myeloid leukemia, or AML, and Behcet’s disease. Due to her rare health problems, she can’t be treated here in the area. Please keep her in your prayers and if you could help ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. After thrombolysis ...

CERO Therapeutics announces first patient dosed in Phase 1 trial of CER-1236 for acute myeloid leukemia, with upcoming ASCO presentation. CERo Therapeutics Holdings, Inc. has announced the initial ...

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric leukemia cases. According to REDECAN, more than 400 new cases are ...

Chronic myeloid leukemia (CML) cells contain an abnormal gene, BCR-ABL, that isn't found in normal cells. This gene makes a protein, BCR-ABL, which causes CML cells to grow and reproduce out of ...